Such findings are useful for developing biological hypotheses, e.g. in this particular case they suggest that in ovarian cancer the extracellular matrix protein 2 is associated with the MAF signature only when the TCF21 gene (a known mesenchymal-epithelial transition mediator) is downregulated. The gene discussed is MAF; the disease is ovarian carcinoma.